177 related articles for article (PubMed ID: 20132151)
41. Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia.
Zuo XL; Li YQ; Li WJ; Guo YT; Lu XF; Li JM; Desmond PV
Clin Exp Allergy; 2007 Jun; 37(6):823-30. PubMed ID: 17517095
[TBL] [Abstract][Full Text] [Related]
42. To "lump" or to "split" the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome?
Moss-Morris R; Spence M
Psychosom Med; 2006; 68(3):463-9. PubMed ID: 16738080
[TBL] [Abstract][Full Text] [Related]
43. Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms.
Beatty JK; Akierman SV; Motta JP; Muise S; Workentine ML; Harrison JJ; Bhargava A; Beck PL; Rioux KP; McKnight GW; Wallace JL; Buret AG
Int J Parasitol; 2017 May; 47(6):311-326. PubMed ID: 28237889
[TBL] [Abstract][Full Text] [Related]
44. Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report.
El-Salhy M; Mazzawi T; Gundersen D; Hatlebakk JG; Hausken T
BMC Res Notes; 2013 Sep; 6():391. PubMed ID: 24073715
[TBL] [Abstract][Full Text] [Related]
45. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M
Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
[TBL] [Abstract][Full Text] [Related]
46. [Changes in tight junction of intestinal mucosa in patients with irritable bowel syndrome: a study with tracing electron microscope].
Kong WM; Gong J; Dong L; Chen MX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1167-70, 1172. PubMed ID: 17715017
[TBL] [Abstract][Full Text] [Related]
47. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis.
Stark D; van Hal S; Marriott D; Ellis J; Harkness J
Int J Parasitol; 2007 Jan; 37(1):11-20. PubMed ID: 17070814
[TBL] [Abstract][Full Text] [Related]
48. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M
Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
[TBL] [Abstract][Full Text] [Related]
49. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis.
Villani AC; Lemire M; Thabane M; Belisle A; Geneau G; Garg AX; Clark WF; Moayyedi P; Collins SM; Franchimont D; Marshall JK
Gastroenterology; 2010 Apr; 138(4):1502-13. PubMed ID: 20044998
[TBL] [Abstract][Full Text] [Related]
50. Functional dyspepsia and irritable bowel syndrome in patients with achalasia and its association with non-cardiac chest pain and a decreased health-related quality of life.
Frankhuisen R; Van Herwaarden MA; Heijkoop R; Baron A; Vermeijden R; Smout AJ; Gooszen HG; Samsom M
Scand J Gastroenterol; 2009; 44(6):687-91. PubMed ID: 19263270
[TBL] [Abstract][Full Text] [Related]
51. [The assessment of personality traits and coping style level among the patients with functional dyspepsia and irritable bowel syndrome].
Wrzesińska MA; Kocur J
Psychiatr Pol; 2008; 42(5):709-17. PubMed ID: 19445354
[TBL] [Abstract][Full Text] [Related]
52. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.
Coëffier M; Gloro R; Boukhettala N; Aziz M; Lecleire S; Vandaele N; Antonietti M; Savoye G; Bôle-Feysot C; Déchelotte P; Reimund JM; Ducrotté P
Am J Gastroenterol; 2010 May; 105(5):1181-8. PubMed ID: 19997094
[TBL] [Abstract][Full Text] [Related]
53. Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome.
Ren TH; Wu J; Yew D; Ziea E; Lao L; Leung WK; Berman B; Hu PJ; Sung JJ
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G849-56. PubMed ID: 17110521
[TBL] [Abstract][Full Text] [Related]
54. Disease burden of post-infectious irritable bowel syndrome in The Netherlands.
Haagsma JA; Siersema PD; De Wit NJ; Havelaar AH
Epidemiol Infect; 2010 Nov; 138(11):1650-6. PubMed ID: 20223049
[TBL] [Abstract][Full Text] [Related]
55. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome.
El-Salhy M; Vaali K; Dizdar V; Hausken T
Dig Dis Sci; 2010 Dec; 55(12):3508-13. PubMed ID: 20300845
[TBL] [Abstract][Full Text] [Related]
56. Sigmoid-colonic motility in health and irritable bowel syndrome: a role for 5-hydroxytryptamine.
Houghton LA; Atkinson W; Lockhart C; Whorwell PJ; Keevil B
Neurogastroenterol Motil; 2007 Sep; 19(9):724-31. PubMed ID: 17539895
[TBL] [Abstract][Full Text] [Related]
57. Central cholecystokinin activity in irritable bowel syndrome, panic disorder, and healthy controls.
Koszycki D; Torres S; Swain JE; Bradwejn J
Psychosom Med; 2005; 67(4):590-5. PubMed ID: 16046372
[TBL] [Abstract][Full Text] [Related]
58. [Signal transduction pathway of colonic Toll-like receptor 4 in patients with irritable bowel syndrome].
Wang XM; Liu YL
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3415-7. PubMed ID: 19159572
[TBL] [Abstract][Full Text] [Related]
59. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.
Dunlop SP; Hebden J; Campbell E; Naesdal J; Olbe L; Perkins AC; Spiller RC
Am J Gastroenterol; 2006 Jun; 101(6):1288-94. PubMed ID: 16771951
[TBL] [Abstract][Full Text] [Related]
60. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
